Using routinely collected patient data to study the impact of type 2 diabetes on breast cancer
We observed significantly poorer OS in women with breast cancer and diabetes across all stages, compared to those without diabetes. Importantly, this persisted after adjusting for confounders and cardiovascular diseases, supporting that diabetes directly influences cancer outcomes.
Authors
- Gema Hernández (ORCID: https://orcid.org/0000-0003-4832-455X)
- Daniel L. Morganstein (ORCID: https://orcid.org/0000-0003-1565-8617)
- Nalinie Joharatnam‐Hogan (ORCID: https://orcid.org/0000-0001-8406-2732)
- Ayaan Khurshed
- Gavin Soady
Institutions
- Royal Marsden NHS Foundation Trust (GB)
- Chelsea and Westminster Hospital NHS Foundation Trust (GB)
- Royal Marsden Hospital (GB)
- TriNetX (United States) (US)
Publication Details
- Journal
- Endocrine Oncology
- Published
- 2025-01-01
- DOI
- https://doi.org/10.1530/eo-24-0039
- Primary Topic
- Metabolism, Diabetes, and Cancer
- Type
- article
- Field-Weighted Citation Impact
- 0.00